A large collection of conserved eukaryotic peptidyl-prolyl cis-trans isomerases. Some members of this group are secreted (into the ER).. Localization: Cytoplasmic (by homology) / ER (by homology)
Chaperone/Protein Folding, cyclophilin 13 CYP13
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0005930 | axoneme | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HX17
Term | Name | Level | Count |
---|---|---|---|
GO:0000413 | protein peptidyl-prolyl isomerization | 7 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0018193 | peptidyl-amino acid modification | 5 | 12 |
GO:0018208 | peptidyl-proline modification | 6 | 12 |
GO:0019538 | protein metabolic process | 3 | 12 |
GO:0036211 | protein modification process | 4 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0043412 | macromolecule modification | 4 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 12 |
GO:0006457 | protein folding | 2 | 1 |
GO:0009987 | cellular process | 1 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003755 | peptidyl-prolyl cis-trans isomerase activity | 3 | 12 |
GO:0003824 | catalytic activity | 1 | 12 |
GO:0016853 | isomerase activity | 2 | 12 |
GO:0016859 | cis-trans isomerase activity | 3 | 12 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 12 |
GO:0005488 | binding | 1 | 1 |
GO:0016018 | cyclosporin A binding | 4 | 1 |
GO:0033218 | amide binding | 2 | 1 |
GO:0042277 | peptide binding | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 167 | 169 | PF00675 | 0.258 |
CLV_NRD_NRD_1 | 7 | 9 | PF00675 | 0.682 |
CLV_NRD_NRD_1 | 97 | 99 | PF00675 | 0.358 |
CLV_PCSK_KEX2_1 | 166 | 168 | PF00082 | 0.259 |
CLV_PCSK_KEX2_1 | 7 | 9 | PF00082 | 0.674 |
CLV_PCSK_KEX2_1 | 97 | 99 | PF00082 | 0.409 |
CLV_PCSK_PC1ET2_1 | 166 | 168 | PF00082 | 0.258 |
CLV_PCSK_SKI1_1 | 281 | 285 | PF00082 | 0.558 |
CLV_PCSK_SKI1_1 | 360 | 364 | PF00082 | 0.667 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.578 |
DOC_CDC14_PxL_1 | 46 | 54 | PF14671 | 0.424 |
DOC_CKS1_1 | 12 | 17 | PF01111 | 0.459 |
DOC_MAPK_DCC_7 | 297 | 305 | PF00069 | 0.463 |
DOC_MAPK_gen_1 | 165 | 174 | PF00069 | 0.266 |
DOC_MAPK_gen_1 | 30 | 40 | PF00069 | 0.456 |
DOC_MAPK_MEF2A_6 | 297 | 305 | PF00069 | 0.463 |
DOC_MAPK_MEF2A_6 | 33 | 42 | PF00069 | 0.313 |
DOC_PP2B_LxvP_1 | 221 | 224 | PF13499 | 0.396 |
DOC_USP7_MATH_1 | 257 | 261 | PF00917 | 0.521 |
DOC_USP7_MATH_1 | 339 | 343 | PF00917 | 0.753 |
DOC_USP7_UBL2_3 | 341 | 345 | PF12436 | 0.655 |
DOC_USP7_UBL2_3 | 356 | 360 | PF12436 | 0.595 |
DOC_WW_Pin1_4 | 11 | 16 | PF00397 | 0.536 |
DOC_WW_Pin1_4 | 115 | 120 | PF00397 | 0.342 |
DOC_WW_Pin1_4 | 252 | 257 | PF00397 | 0.701 |
DOC_WW_Pin1_4 | 272 | 277 | PF00397 | 0.697 |
DOC_WW_Pin1_4 | 318 | 323 | PF00397 | 0.651 |
DOC_WW_Pin1_4 | 332 | 337 | PF00397 | 0.501 |
DOC_WW_Pin1_4 | 69 | 74 | PF00397 | 0.535 |
LIG_14-3-3_CanoR_1 | 281 | 286 | PF00244 | 0.756 |
LIG_14-3-3_CanoR_1 | 30 | 36 | PF00244 | 0.402 |
LIG_APCC_ABBA_1 | 82 | 87 | PF00400 | 0.315 |
LIG_BRCT_BRCA1_1 | 186 | 190 | PF00533 | 0.291 |
LIG_CSL_BTD_1 | 158 | 161 | PF09270 | 0.250 |
LIG_FHA_1 | 139 | 145 | PF00498 | 0.266 |
LIG_FHA_1 | 20 | 26 | PF00498 | 0.569 |
LIG_FHA_1 | 4 | 10 | PF00498 | 0.550 |
LIG_FHA_2 | 282 | 288 | PF00498 | 0.670 |
LIG_FHA_2 | 70 | 76 | PF00498 | 0.527 |
LIG_Integrin_isoDGR_2 | 202 | 204 | PF01839 | 0.285 |
LIG_LIR_Gen_1 | 124 | 133 | PF02991 | 0.266 |
LIG_LIR_Gen_1 | 216 | 225 | PF02991 | 0.362 |
LIG_LIR_Gen_1 | 233 | 239 | PF02991 | 0.166 |
LIG_LIR_Gen_1 | 34 | 43 | PF02991 | 0.306 |
LIG_LIR_Gen_1 | 76 | 85 | PF02991 | 0.329 |
LIG_LIR_Nem_3 | 124 | 129 | PF02991 | 0.280 |
LIG_LIR_Nem_3 | 216 | 221 | PF02991 | 0.373 |
LIG_LIR_Nem_3 | 233 | 238 | PF02991 | 0.166 |
LIG_LIR_Nem_3 | 34 | 40 | PF02991 | 0.310 |
LIG_LIR_Nem_3 | 44 | 49 | PF02991 | 0.409 |
LIG_LIR_Nem_3 | 76 | 82 | PF02991 | 0.409 |
LIG_MLH1_MIPbox_1 | 186 | 190 | PF16413 | 0.266 |
LIG_PDZ_Class_2 | 361 | 366 | PF00595 | 0.600 |
LIG_SH2_CRK | 114 | 118 | PF00017 | 0.256 |
LIG_SH2_CRK | 235 | 239 | PF00017 | 0.315 |
LIG_SH2_NCK_1 | 152 | 156 | PF00017 | 0.396 |
LIG_SH2_STAP1 | 235 | 239 | PF00017 | 0.315 |
LIG_SH2_STAT3 | 112 | 115 | PF00017 | 0.266 |
LIG_SH2_STAT3 | 133 | 136 | PF00017 | 0.396 |
LIG_SH2_STAT3 | 296 | 299 | PF00017 | 0.549 |
LIG_SH2_STAT5 | 112 | 115 | PF00017 | 0.309 |
LIG_SH2_STAT5 | 121 | 124 | PF00017 | 0.292 |
LIG_SH2_STAT5 | 125 | 128 | PF00017 | 0.276 |
LIG_SH2_STAT5 | 133 | 136 | PF00017 | 0.270 |
LIG_SH2_STAT5 | 24 | 27 | PF00017 | 0.565 |
LIG_SH3_2 | 336 | 341 | PF14604 | 0.549 |
LIG_SH3_3 | 333 | 339 | PF00018 | 0.724 |
LIG_SH3_3 | 44 | 50 | PF00018 | 0.373 |
LIG_TRAF2_1 | 284 | 287 | PF00917 | 0.699 |
LIG_TRAF2_1 | 72 | 75 | PF00917 | 0.544 |
MOD_CK1_1 | 151 | 157 | PF00069 | 0.396 |
MOD_CK1_1 | 17 | 23 | PF00069 | 0.481 |
MOD_CK1_1 | 184 | 190 | PF00069 | 0.266 |
MOD_CK1_1 | 251 | 257 | PF00069 | 0.726 |
MOD_CK1_1 | 26 | 32 | PF00069 | 0.462 |
MOD_CK1_1 | 260 | 266 | PF00069 | 0.605 |
MOD_CK1_1 | 352 | 358 | PF00069 | 0.530 |
MOD_CK2_1 | 264 | 270 | PF00069 | 0.592 |
MOD_CK2_1 | 281 | 287 | PF00069 | 0.663 |
MOD_CK2_1 | 69 | 75 | PF00069 | 0.534 |
MOD_GlcNHglycan | 153 | 156 | PF01048 | 0.396 |
MOD_GlcNHglycan | 16 | 19 | PF01048 | 0.454 |
MOD_GlcNHglycan | 193 | 196 | PF01048 | 0.322 |
MOD_GlcNHglycan | 250 | 253 | PF01048 | 0.614 |
MOD_GlcNHglycan | 281 | 284 | PF01048 | 0.653 |
MOD_GlcNHglycan | 322 | 325 | PF01048 | 0.701 |
MOD_GSK3_1 | 117 | 124 | PF00069 | 0.345 |
MOD_GSK3_1 | 146 | 153 | PF00069 | 0.347 |
MOD_GSK3_1 | 19 | 26 | PF00069 | 0.461 |
MOD_GSK3_1 | 248 | 255 | PF00069 | 0.578 |
MOD_GSK3_1 | 260 | 267 | PF00069 | 0.593 |
MOD_GSK3_1 | 268 | 275 | PF00069 | 0.629 |
MOD_GSK3_1 | 277 | 284 | PF00069 | 0.725 |
MOD_GSK3_1 | 345 | 352 | PF00069 | 0.715 |
MOD_GSK3_1 | 48 | 55 | PF00069 | 0.432 |
MOD_GSK3_1 | 69 | 76 | PF00069 | 0.418 |
MOD_LATS_1 | 358 | 364 | PF00433 | 0.555 |
MOD_N-GLC_1 | 184 | 189 | PF02516 | 0.313 |
MOD_NEK2_1 | 189 | 194 | PF00069 | 0.283 |
MOD_NEK2_1 | 19 | 24 | PF00069 | 0.489 |
MOD_NEK2_1 | 250 | 255 | PF00069 | 0.585 |
MOD_NEK2_1 | 340 | 345 | PF00069 | 0.694 |
MOD_NEK2_1 | 52 | 57 | PF00069 | 0.462 |
MOD_NEK2_1 | 63 | 68 | PF00069 | 0.439 |
MOD_NEK2_2 | 138 | 143 | PF00069 | 0.266 |
MOD_PIKK_1 | 184 | 190 | PF00454 | 0.266 |
MOD_PIKK_1 | 257 | 263 | PF00454 | 0.701 |
MOD_PIKK_1 | 41 | 47 | PF00454 | 0.505 |
MOD_PIKK_1 | 52 | 58 | PF00454 | 0.521 |
MOD_Plk_1 | 138 | 144 | PF00069 | 0.266 |
MOD_Plk_1 | 73 | 79 | PF00069 | 0.516 |
MOD_Plk_4 | 121 | 127 | PF00069 | 0.262 |
MOD_Plk_4 | 245 | 251 | PF00069 | 0.571 |
MOD_Plk_4 | 74 | 80 | PF00069 | 0.443 |
MOD_ProDKin_1 | 11 | 17 | PF00069 | 0.535 |
MOD_ProDKin_1 | 115 | 121 | PF00069 | 0.342 |
MOD_ProDKin_1 | 252 | 258 | PF00069 | 0.699 |
MOD_ProDKin_1 | 272 | 278 | PF00069 | 0.696 |
MOD_ProDKin_1 | 318 | 324 | PF00069 | 0.651 |
MOD_ProDKin_1 | 332 | 338 | PF00069 | 0.503 |
MOD_ProDKin_1 | 69 | 75 | PF00069 | 0.534 |
TRG_DiLeu_BaEn_1 | 245 | 250 | PF01217 | 0.453 |
TRG_DiLeu_BaEn_3 | 74 | 80 | PF01217 | 0.489 |
TRG_ENDOCYTIC_2 | 114 | 117 | PF00928 | 0.304 |
TRG_ENDOCYTIC_2 | 235 | 238 | PF00928 | 0.368 |
TRG_ER_diArg_1 | 7 | 9 | PF00400 | 0.628 |
TRG_ER_diArg_1 | 96 | 98 | PF00400 | 0.370 |
TRG_NLS_MonoCore_2 | 164 | 169 | PF00514 | 0.256 |
TRG_NLS_MonoExtC_3 | 165 | 171 | PF00514 | 0.388 |
TRG_NLS_MonoExtN_4 | 165 | 170 | PF00514 | 0.388 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IJB8 | Leptomonas seymouri | 79% | 100% |
A0A1X0P0F8 | Trypanosomatidae | 58% | 100% |
A0A3Q8IDR1 | Leishmania donovani | 100% | 100% |
A0A3R7MER6 | Trypanosoma rangeli | 57% | 100% |
A4H8P7 | Leishmania braziliensis | 78% | 95% |
A4HHU7 | Leishmania braziliensis | 30% | 100% |
C9ZVY5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 57% | 100% |
E9AQT1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 99% |
Q4IPB3 | Gibberella zeae (strain ATCC MYA-4620 / CBS 123657 / FGSC 9075 / NRRL 31084 / PH-1) | 24% | 67% |
Q4QEP7 | Leishmania major | 94% | 100% |
V5DJ29 | Trypanosoma cruzi | 59% | 100% |